Secura Bio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Secura Bio, Inc. - overview
Established
2019
Location
Las Vegas, NV, US
Primary Industry
Pharmaceuticals
About
Founded in 2019. Based in Nevada, US, Secura Bio, Inc. is a biopharmaceutical company that engages in developing and commercializing medicines and oncology therapies for doctors and their patients. The company offers FARYDAK, a treatment for patients with cancer called multiple myeloma.
Current Investors
Athyrium Capital Management
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.securabio.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.